VISWANADHAN KRISHNAN (Chief Corp Dev & Strategy) sold 22.3% of their position (2.96K shares) of AGIOS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $102.7K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/6/2026ACC: 0001439222-26-000059
Officer· Chief Corp Dev & Strategy
Since Mar 2026
-2.96K
Net shares
Net seller
$102.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
8.10K acquired · 11.06K disposed
Non-Derivative Transactions2
Common stock
Direct
Shares
+8.10K
Price / share
—
Trade value
—
% of position
157.6%
4/2/2026
5.14K→13.24K
Common stock
Direct
Shares
−2.96K
Price / share
$34.71
Trade value
$102.71K
% of position
22.3%
4/2/2026
13.24K→10.28K
Total
Net shares
+5.14K
Net value
-$102.71K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 4/2/2026 | M · Option Exercise | +8.10K | — | — | 157.6% | 5.14K | 13.24K |
| Common stock Direct | 4/2/2026 | S · Sale | −2.96K | $34.71 | $102.71K | 22.3% | 13.24K | 10.28K |
| Total | +5.14K | -$102.71K | ||||||
Derivative Transactions1
Performance share units
Direct
Converts to
Common stock
8.10K shares
Shares
−8.10K
Strike price
Held after
8.10K
Exercisable
—
4/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Performance share units Direct | Common stock8.10K shares | 4/2/2026 | M · Option Exercise | −8.10K | — | 8.10K |